Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05985629 · ClinicalTrials.gov registry record · Phase 4

IPACK on Early Pain Scores After ACL Reconstruction

A Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries, sponsored by Loyola University.

Recruiting
Registry status
Phase 4
Development phase
78
Enrollment target
1
Study location

NCT05985629 is a Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries that is actively recruiting participants, run by Loyola University. The registered enrollment target is 78 participants, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (71% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05985629, a Phase 4 study of Pain, Postoperative and Anterior Cruciate Ligament Injuries, is actively recruiting participants, sponsored by Loyola University.

RECRUITING
Registry status
Phase 4
Development phase
78 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after surgery and at 1 day after surgery * if participants who receive the IPACK block prior to ACL reconstruction require less short-term opioid use immediately after surgery and up to one week after surgery. Participants will be randomized 1:1 to 1 of 2 groups: Use of IPACK block during ACL reconstruction vs. placebo (a placebo is a look-alike substance that contains no active drug). Neither the participant nor the investigator will know which group the participants has been assigned to. Researchers will compare self-reported pain scores and short-term opioid use of all study participants.

Interventions

  • DRUG IPACK
  • DRUG PLACEBO

Study Locations (1)

Illinois

  • Loyola University Medical Center - Maywood

Trial Details

FieldValue
Enrollment Target 78 participants
Start Date 2023-08-03
Est. Completion 2026-08-03
Phase Phase 4

Sponsor

Loyola University

92 total trials

What the Registry Record Tells You About NCT05985629

The ClinicalTrials.gov registry entry for NCT05985629 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 78 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 272-participant average among 108 other Pain, Postoperative trials with a reported enrollment target (71% lower). The listed sponsor is Loyola University, which has 92 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain, Postoperative appearing as the primary indexed condition, and to 2 interventions - of which IPACK is the first listed.

NCT05985629 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT05985629 about?

NCT05985629 is a clinical study titled "IPACK on Early Pain Scores After ACL Reconstruction". The goal of this clinical trial is to learn whether using an anesthetic technique called IPACK block will control pain after ACL reconstruction surgery. The main questions it aims to answer are: * if participants who receive the IPACK block prior to ACL reconstruction experience less pain after sur...

What is the current status of trial NCT05985629?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 78 participants. The study started on 2023-08-03. Estimated completion is 2026-08-03.

What conditions does trial NCT05985629 study?

This clinical trial studies the following conditions: Pain, Postoperative, Anterior Cruciate Ligament Injuries, Analgesics, Opioid.

What interventions are being tested in trial NCT05985629?

The interventions under investigation include: IPACK (DRUG), PLACEBO (DRUG).

Who is sponsoring clinical trial NCT05985629?

This trial is sponsored by Loyola University, which has 92 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05985629 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Postoperative

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.